Medicine
Meloxicam 15 mg tablet
Meloxicam 15 mg tablet is a generic prescription medicine for oral use, made by 38 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Meloxicam
- Brand
- Sold under the generic name
- Strength
- 15 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 90 tablets and 295 more
- Manufacturers
- Zydus LifesciencesIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaCiplaIndiaXLCare PharmaceuticalsAiPing PharmaceuticalChartwell RXExelan PharmaceuticalsCarlsbad Technology38 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M01AC06 Meloxicam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 July 2006
- Identifiers
- RxCUI 152695, 311486DailyMed set ID 58dbce26-b2ac-2ce4-e063-6294a90a5727, f31d181a-33cb-560f-e053-2995a90abbd9, fabd063a-d3a5-44a3-90a2-e33d721b7a95 +37NDC 72189-684, 51655-571, 70518-1828 +37Application ANDA077882, ANDA077929, ANDA077921 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 38 labelers. The register lists 298 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65841-051-01 | Zydus LifesciencesIndia | 19 July 2006 |
| 500 tablet in 1 bottle | 65841-051-05 | Zydus LifesciencesIndia | 19 July 2006 |
| 90 tablet in 1 bottle | 65841-051-16 | Zydus LifesciencesIndia | 19 July 2006 |
| 5000 tablet in 1 bottle | 65841-051-40 | Zydus LifesciencesIndia | 19 July 2006 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 65841-051-77 | Zydus LifesciencesIndia | 19 July 2006 |
| 100 tablet in 1 bottle | 68382-051-01 | Zydus LifesciencesIndia | 19 July 2006 |
| 500 tablet in 1 bottle | 68382-051-05 | Zydus LifesciencesIndia | 19 July 2006 |
| 90 tablet in 1 bottle | 68382-051-16 | Zydus LifesciencesIndia | 19 July 2006 |
| 5000 tablet in 1 bottle | 68382-051-40 | Zydus LifesciencesIndia | 19 July 2006 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 68382-051-77 | Zydus LifesciencesIndia | 19 July 2006 |
| 100 tablet in 1 bottle | 65862-098-01 | Aurobindo PharmaIndia | 2 October 2006 |
| 500 tablet in 1 bottle | 65862-098-05 | Aurobindo PharmaIndia | 2 October 2006 |
| 1000 tablet in 1 bottle | 65862-098-99 | Aurobindo PharmaIndia | 2 October 2006 |
| 100 tablet in 1 bottle | 31722-227-01 | Camber PharmaceuticalsIndia | 8 June 2023 |
| 500 tablet in 1 bottle | 31722-227-05 | Camber PharmaceuticalsIndia | 8 June 2023 |
| 1000 tablet in 1 bottle | 31722-227-31 | Camber PharmaceuticalsIndia | 8 June 2023 |
| 100 tablet in 1 bottle | 69097-159-07 | CiplaIndia | 19 July 2006 |
| 500 tablet in 1 bottle | 69097-159-12 | CiplaIndia | 19 July 2006 |
| 1000 tablet in 1 bottle | 69097-159-15 | CiplaIndia | 19 July 2006 |
| 100 tablet in 1 bottle | 29300-125-01 | Unichem LaboratoriesIndia | 7 March 2007 |
| 500 tablet in 1 bottle | 29300-125-05 | Unichem LaboratoriesIndia | 31 July 2024 |
| 1000 tablet in 1 bottle | 29300-125-10 | Unichem LaboratoriesIndia | 7 March 2007 |
| 30 tablet in 1 bottle | 29300-125-13 | Unichem LaboratoriesIndia | 7 March 2007 |
| 90 tablet in 1 bottle | 29300-125-19 | Unichem LaboratoriesIndia | 18 February 2022 |
| 5000 tablet in 1 bottle | 29300-125-50 | Unichem LaboratoriesIndia | 7 March 2007 |
| 100 tablet in 1 bottle | 11788-047-01 | AiPing Pharmaceutical | 15 December 2025 |
| 500 tablet in 1 bottle | 11788-047-05 | AiPing Pharmaceutical | 15 December 2025 |
| 1000 tablet in 1 bottle | 11788-047-10 | AiPing Pharmaceutical | 15 December 2025 |
| 83000 tablet in 1 carton | 11788-099-00 | AiPing Pharmaceutical | 2 May 2024 |
| 100 tablet in 1 bottle | 72865-138-01 | XLCare Pharmaceuticals | 17 February 2020 |
| 1000 tablet in 1 bottle | 72865-138-10 | XLCare Pharmaceuticals | 17 February 2020 |
| 90 tablet in 1 bottle | 72865-138-90 | XLCare Pharmaceuticals | 17 February 2020 |
| 100 tablet in 1 bottle | 72865-333-01 | XLCare Pharmaceuticals | 12 December 2025 |
| 1000 tablet in 1 bottle | 72865-333-10 | XLCare Pharmaceuticals | 12 December 2025 |
| 90 tablet in 1 bottle | 72865-333-90 | XLCare Pharmaceuticals | 12 December 2025 |
| 1000 tablet in 1 bottle, plastic | 61442-127-10 | Carlsbad Technology | 30 June 2010 |
| 180 tablet in 1 bottle | 62135-716-18 | Chartwell RX | 2 October 2023 |
| 90 tablet in 1 bottle | 62135-716-90 | Chartwell RX | 2 October 2023 |
| 100 tablet in 1 bottle | 76282-153-01 | Exelan Pharmaceuticals | 14 April 2015 |
| 500 tablet in 1 bottle | 76282-153-05 | Exelan Pharmaceuticals | 14 April 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 April 2000 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meloxicam
Clinical summary
Meloxicam is a nonsteroidal anti-inflammatory drug indicated for osteoarthritis (OA), among other approved uses. It is available as tablets, capsules and oral suspension for intravenous use. MedsAcross supplies Meloxicam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeloxicamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Meloxicam prescribing information (Avondale Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Meloxicam 15 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.